NIMG-58 PRELIMINARY TRENDS IN ADVANCED IMAGING RELATIVE TO STANDARD IMAGING IN SUBJECTS TREATED WITH OPTUNE

od Prah, Melissa, Connelly, Jennifer, Schmainda, Kathleen
Wydane w Neuro Oncol (2015)

NIMG-01 ADVANCED MR PERFUSION AND DIFFUSION MEASURES DISTINGUISH BETWEEN GLIOMA SUBTYPES

od Al-Gizawiy, Mona, Prah, Melissa, Mueller, Wade, Schmainda, Kathleen
Wydane w Neuro Oncol (2015)

NIMG-67. ADVANCED PERFUSION AND DIFFUSION MR IMAGING IN GLIOBLASTOMA PATIENTS TREATED WITH TUMOR TREATING FIELDS (TTFIELDS) AS FIRST-LINE THERAPY

od Connelly, Jennifer M, Prah, Melissa A, Schmainda, Kathleen M
Wydane w Neuro Oncol (2017)

NI-65 DIFFERENTIATING RADIATION EFFECT AND NECROSIS FROM GLIOBLASTOMA WITH DYNAMIC SUSCEPTIBILITY CONTRAST (DSC) MRI

od Prah, Melissa, Al-Gizawiy, Mona, Mueller, Wade, Hoffmann, Raymond, Schmainda, Kathleen
Wydane 2014

NI-03 DSC-MRI MEASURES OF rCBV PREDICT TUMOR CHARACTERISTICS BEYOND STANDARD HISTOPATHOLOGY

od Al-Gizawiy, Mona, Prah, Melissa, Mueller, Wade, LaViolette, Peter, Schmainda, Kathleen
Wydane 2014

OT-01 EFFECTIVENESS OF PERFUSION AND DIFFUSION IMAGING FOR GRADING PEDIATRIC BRAIN TUMORS

od Kelly, Teresa, Prah, Melissa, Jogal, Sachin, Maheshwari, Mohit, Lew, Sean, Schmainda, Kathleen
Wydane w Neuro Oncol (2015)

TMOD-25. IN VIVO MODEL OF TREATMENT-RESISTANT GLIOBLASTOMA HIGHLIGHTS SEX DIFFERENCES IN SURVIVAL

od Al-Gizawiy, Mona, Wujek, Robert, Prah, Melissa, Molino, Salvatore, Chitambar, Christopher, Schmainda, Kathleen
Wydane w Neuro Oncol (2020)

Presumed Hydrogen Sulfide-Mediated Neurotoxicity Following Streptococcus Anginosus Group Meningitis

od Verma, Sumit, Landisch, Rachel, Quirk, Brendan, Schmainda, Kathleen, Prah, Melissa, Whelan, Harry T., Willoughby, Rodney E.
Wydane 2013

Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial

od Schmainda, Kathleen M, Prah, Melissa A, Marques, Helga, Kim, Eunhee, Barboriak, Daniel P, Boxerman, Jerrold L
Wydane w Neuro Oncol (2020)

EXTH-48. ORAL GALLIUM MALTOLATE IMPAIRS TUMOR GROWTH AND EXTENDS DISEASE-SPECIFIC SURVIVAL IN A XENOGRAFT MODEL OF RECURRENT GBM

od Al-Gizawiy, Mona, Robert, Wujek, Alhajala, Hisham, Cobb, Jonathan, Prah, Melissa, Mirza, Shama, Chitambar, Christopher, Schmainda, Kathleen
Wydane w Neuro Oncol (2018)

Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma

od Schmainda, Kathleen M., Prah, Melissa, Connelly, Jennifer, Rand, Scott D., Hoffman, Raymond G., Mueller, Wade, Malkin, Mark G.
Wydane 2014

Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RT...

od Schmainda, Kathleen M., Zhang, Zheng, Prah, Melissa, Snyder, Bradley S., Gilbert, Mark R., Sorensen, A. Gregory, Barboriak, Daniel P., Boxerman, Jerrold L.
Wydane w Neuro Oncol (2015)

THER-12. NOVEL IRON-TARGETED THERAPY IS HIGHLY EFFECTIVE IN TREATMENT-RESISTANT HIGH-GRADE GLIOMA IN VIVO

od Al-Gizawiy, Mona, Wujek, Robert, Prah, Melissa, Knipstein, Jeffrey, Alhajala, Hisham, Doan, Ninh, Molino, Salvatore, Mirza, Shama, Chitambar, Christopher, Schmainda, Kathleen
Wydane w Neuro Oncol (2019)

The Effects of Perfusion on Diffusion Changes in Human Brain Tumors

od Cohen, Alexander D., LaViolette, Peter S., Prah, Melissa, Connelly, Jennifer, Malkin, Mark G., Rand, Scott D., Mueller, Wade M., Schmainda, Kathleen M.
Wydane 2013

Spatial Discrimination of Glioblastoma And Treatment Effect With Histologically-Validated Perfusion And Diffusion Magnetic Resonance Imaging Metrics

od Prah, Melissa A, Al-Gizawiy, Mona M, Mueller, Wade M, Cochran, Elizabeth J, Hoffmann, Raymond G, Connelly, Jennifer M, Schmainda, Kathleen M
Wydane w J Neurooncol (2017)

Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma

od LaViolette, Peter S., Cohen, Alex D., Prah, Melissa A., Rand, Scott D., Connelly, Jennifer, Malkin, Mark. G., Mueller, Wade. M., Schmainda, Kathleen M.
Wydane 2013

NIMG-28. VALIDATION OF SINGLE-DOSE DSC-MRI PROTOCOLS FOR ROBUST PERFUSION ASSESSMENT IN BRAIN TUMORS

od Quarles, Chad, Bell, Laura, Semmineh, Natenael, Fuentes, Alberto, Prah, Melissa, Nespodzany, Ashley, Alhilai, Lea, Karis, John, Rand, Scott, Dardis, Chris, Braun, Kelly, Connelly, Jennifer, Zhou, Yuxiang, Schmainda, Kathleen, Hu, Leland, Boxerman, Jerry, Stokes, Ashley
Wydane w Neuro Oncol (2019)

ACRIN 6684: Assessment of tumor hypoxia in newly diagnosed GBM using (18)F-FMISO PET and MRI

od Gerstner, Elizabeth R., Zhang, Zheng, Fink, James R., Muzi, Mark, Hanna, Lucy, Greco, Erin, Prah, Melissa, Schmainda, Kathleen M, Mintz, Akiva, Kostakoglu, Lale, Eikman, Edward A., Ellingson, Benjamin M., Ratai, Eva-Maria, Sorensen, Gregory, Barboriak, Daniel P., Mankoff, David
Wydane w Clin Cancer Res (2016)

ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy

od Ratai, Eva-Maria, Zhang, Zheng, Fink, James, Muzi, Mark, Hanna, Lucy, Greco, Erin, Richards, Todd, Kim, Daniel, Andronesi, Ovidiu C., Mintz, Akiva, Kostakoglu, Lale, Prah, Melissa, Ellingson, Benjamin, Schmainda, Kathleen, Sorensen, Gregory, Barboriak, Daniel, Mankoff, David, Gerstner, Elizabeth R.
Wydane w PLoS One (2018)

Toward uniform implementation of parametric map Digital Imaging and Communication in Medicine standard in multisite quantitative diffusion imaging studies

od Malyarenko, Dariya, Fedorov, Andriy, Bell, Laura, Prah, Melissa, Hectors, Stefanie, Arlinghaus, Lori, Muzi, Mark, Solaiyappan, Meiyappan, Jacobs, Michael A., Fung, Maggie, Shukla-Dave, Amita, McManus, Kevin, Boss, Michael, Taouli, Bachir, Yankeelov, Thomas E., Quarles, Christopher Chad, Schmainda, Kathleen, Chenevert, Thomas L., Newitt, David C.
Wydane w J Med Imaging (Bellingham) (2017)